PMV PHARMACEUTICALS, INC. Basic Shares Outstanding (Weighted Average)
PMV PHARMACEUTICALS, INC. (PMVP) reported Basic Shares Outstanding (Weighted Average) of 53.39 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-14
- PMV PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 53.39M shares, a 2.65% increase year-over-year.
- PMV PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 53.33M shares, a 2.66% increase year-over-year.
- PMV PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 53.20M shares, a 2.67% increase year-over-year.
- PMV PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 52.99M shares, a 2.75% increase year-over-year.
- PMV PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 52.54M shares, a 1.87% increase from fiscal 2024.
- PMV PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 51.58M shares, a 7.42% increase from fiscal 2023.
- PMV PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 48.01M shares, a 5.31% increase from fiscal 2022.
- PMV PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 45.59M shares, a 1.01% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 53.39M shares 10-Q · filed 2026-08-14 | 53.36M shares 10-Q · filed 2026-08-14 | 53.31M shares derived: average of 3 quarters · filed 2026-08-14 | 53.23M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | 53.33M shares 10-Q · filed 2026-05-12 | 53.27M shares derived: average of 2 quarters · filed 2026-05-12 | 53.17M shares derived: average of 3 quarters · filed 2026-05-12 | 52.88M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | 53.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | 53.10M shares derived: average of 2 quarters · filed 2026-03-06 | 52.73M shares derived: average of 3 quarters · filed 2026-08-14 | 52.54M shares 10-K · filed 2026-03-06 |
| 2025-09-30 | 52.99M shares 10-Q · filed 2025-11-12 | 52.50M shares derived: average of 2 quarters · filed 2026-08-14 | 52.32M shares 10-Q · filed 2025-11-12 | 52.19M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | 52.01M shares 10-Q · filed 2026-08-14 | 51.98M shares 10-Q · filed 2026-08-14 | 51.93M shares derived: average of 3 quarters · filed 2026-08-14 | 51.84M shares derived: average of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | 51.95M shares 10-Q · filed 2026-05-12 | 51.88M shares derived: average of 2 quarters · filed 2026-05-12 | 51.78M shares derived: average of 3 quarters · filed 2026-05-12 | 51.71M shares derived: average of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | 51.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | 51.69M shares derived: average of 2 quarters · filed 2026-03-06 | 51.62M shares derived: average of 3 quarters · filed 2026-03-06 | 51.58M shares 10-K · filed 2026-03-06 |
| 2024-09-30 | 51.57M shares 10-Q · filed 2025-11-12 | 51.53M shares derived: average of 2 quarters · filed 2025-11-12 | 51.50M shares 10-Q · filed 2025-11-12 | 51.47M shares derived: average of 4 quarters · filed 2026-03-06 |
| 2024-06-30 | 51.48M shares 10-Q · filed 2025-08-07 | 51.46M shares 10-Q · filed 2025-08-07 | 51.44M shares derived: average of 3 quarters · filed 2026-03-06 | 50.84M shares derived: average of 4 quarters · filed 2026-03-06 |
| 2024-03-31 | 51.45M shares 10-Q · filed 2025-05-09 | 51.42M shares derived: average of 2 quarters · filed 2026-03-06 | 50.63M shares derived: average of 3 quarters · filed 2026-03-06 | 49.42M shares derived: average of 4 quarters · filed 2026-03-06 |
| 2023-12-31 | 51.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | 50.22M shares derived: average of 2 quarters · filed 2026-03-06 | 48.75M shares derived: average of 3 quarters · filed 2026-03-06 | 48.01M shares 10-K · filed 2026-03-06 |
| 2023-09-30 | 49.05M shares 10-Q · filed 2024-11-07 | 47.43M shares derived: average of 2 quarters · filed 2024-11-07 | 46.89M shares 10-Q · filed 2024-11-07 | 46.59M shares derived: average of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | 45.81M shares 10-Q · filed 2024-08-08 | 45.79M shares 10-Q · filed 2024-08-08 | 45.77M shares derived: average of 3 quarters · filed 2025-03-03 | 45.73M shares derived: average of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | 45.77M shares 10-Q · filed 2024-05-09 | 45.74M shares derived: average of 2 quarters · filed 2025-03-03 | 45.70M shares derived: average of 3 quarters · filed 2025-03-03 | 45.67M shares derived: average of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | 45.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 45.67M shares derived: average of 2 quarters · filed 2025-03-03 | 45.63M shares derived: average of 3 quarters · filed 2025-03-03 | 45.59M shares 10-K · filed 2025-03-03 |
| 2022-09-30 | 45.62M shares 10-Q · filed 2023-11-09 | 45.60M shares derived: average of 2 quarters · filed 2023-11-09 | 45.56M shares 10-Q · filed 2023-11-09 | 45.51M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | 45.57M shares 10-Q · filed 2023-08-09 | 45.52M shares 10-Q · filed 2023-08-09 | 45.48M shares derived: average of 3 quarters · filed 2024-02-29 | 45.43M shares derived: average of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | 45.47M shares 10-Q · filed 2023-05-10 | 45.43M shares derived: average of 2 quarters · filed 2024-02-29 | 45.39M shares derived: average of 3 quarters · filed 2024-02-29 | |
| 2021-12-31 | 45.39M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 45.34M shares derived: average of 2 quarters · filed 2024-02-29 | 45.14M shares 10-K · filed 2024-02-29 | |
| 2021-09-30 | 45.30M shares 10-Q · filed 2022-11-08 | 45.05M shares 10-Q · filed 2022-11-08 | ||
| 2020-12-31 | 14.36M shares 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |